Microsoft Vs. Akero Therapeutics Industry Stock Comparison

Buy

62

MSFT
Microsoft

Last Price:

$503.15

Seasonality Move:

2.98%

Sell

42

AKRO
Akero Therapeutics

Last Price:

$51.57

Seasonality Move:

45.38%

Buy

62

Microsoft (MSFT) is a Buy

Is Microsoft a Buy, Sell or Hold?

The current Microsoft [MSFT] share price is $503.32. The Score for MSFT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
MSFT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

42

Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

The current Akero Therapeutics [AKRO] share price is $51.57. The Score for AKRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MSFT Stock Price Chart

What is Microsoft's stock price today?

The Microsoft share price today is $503.32

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSFT is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

The Akero Therapeutics share price today is $51.57

The current trend is moderately bearish and AKRO is experiencing slight selling pressure.

MSFT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	111.61	Buy
Relative Strength Index (14 RSI):	71.71	Buy
Chaikin Money Flow:	8679065	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(475.21 - 498.13)	Buy
Bollinger Bands (100):	(382.2 - 471.6)	Buy

AKRO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.36	Buy
Relative Strength Index (14 RSI):	49.06	Sell
Chaikin Money Flow:	-3310	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(51.91 - 55.31)	Sell
Bollinger Bands (100):	(40.14 - 51.98)	Buy

MSFT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	498.08	Buy
20-day SMA:	490.62	Buy
50-day SMA:	467.24	Buy
200-day SMA:	426.08	Buy
8-day EMA:	318.14	Buy
20-day EMA:	165.43	Buy
50-day EMA:	74.13	Buy
200-day EMA:	19.65	Buy

AKRO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	51.46	Buy
20-day SMA:	53.5	Sell
50-day SMA:	49.2	Buy
200-day SMA:	39.21	Buy
8-day EMA:	51.9	Sell
20-day EMA:	52.24	Sell
50-day EMA:	49.79	Buy
200-day EMA:	40.99	Buy

Microsoft Earnings Growth & MSFT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.06 per share, an increase this year of $1.57 per share, and an increase next year of $1.73 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Microsoft Technical Analysis

	Jun 27	Jun 30	Jul 1	Jul 2	Jul 3	Jul 7	Jul 8	Jul 9	Jul 10	Jul 11
	Jun			Jul
	27	30	01	02	03	07	08	09	10	11
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

	Jun 27	Jun 30	Jul 1	Jul 2	Jul 3	Jul 7	Jul 8	Jul 9	Jul 10	Jul 11
	Jun			Jul
	27	30	01	02	03	07	08	09	10	11
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):